In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took researchers by surprise.

And while there are no strong studies directly comparing the two, it seems like Mounjaro might be more effective for weight loss. Mounjaro and Ozempic are both diabetes drugs prescribed off-label ...

With weight loss drugs like metformin and Ozempic gaining popularity, it's essential to understand how they compare. So we ...

Ozempic, an anti-diabetes medication, has gained popularity for its off-label use in weight loss among celebrities, despite ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

Unlike other weight-loss medications, Ozempic also improves insulin sensitivity ... its off-label use among non-diabetic individuals raises important safety concerns, according to Dr Mahesh.

It may lower the risk of heart and blood disorders such as deep vein thrombosis and heart attack, as well as neurocognitive ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

Researchers have found links to multiple new benefits – and new side effects – in a study of weight-loss drugs such as ...

Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing dozens of health conditions. But the semaglutide-like drugs also appear to ...

The use of weight-loss jabs may be associated with wider health benefits including lower risk of stroke and dementia, a study ...